Shariah compliance overview
Not HalalPuma Biotechnology, Inc. (PBYI) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Puma Biotechnology, Inc.
Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications.
Puma Biotechnology, Inc. (PBYI) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Interest-bearing securities and assets.
- Business Activity
- 1.76%Limit 5%Pass
- Interest-bearing debt
- 10.23%Limit 30%Pass
- Interest-bearing securities and assets
- 44.32%Limit 30%Fail
- Dividend purification
- 1.76%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Puma Biotechnology, Inc. (PBYI). Current Akinda screening label: Not Halal.
